Recurrence Clinical Trials in Beijing, Beijing Municipality
6 recruitingBeijing, Beijing Municipality, China
Showing 1–6 of 6 trials
Recruiting
Phase 2
Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences30 enrolled4 locationsNCT07239245
Recruiting
Phase 4
Impact of Remimazolam on Prognosis After Bladder Cancer Surgery
SurgeryBladder CancerCancer Recurrence+2 more
Peking University First Hospital1,128 enrolled6 locationsNCT04532606
Recruiting
Phase 1
BC008-1A Injection for Recurrent CNS WHO G4 Glioma
GliomaGlioblastoma WHO Grade IVGlioma Tumor Recurrence+2 more
Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.40 enrolled1 locationNCT06773481
Recruiting
Phase 1Phase 2
B7-H3 NIR Imaging for Osteosarcoma Surgery
OsteosarcomaResection MarginsB7-H3 Probe+1 more
Peking University People's Hospital32 enrolled1 locationNCT06778603
Recruiting
Phase 2
Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
SurgeryThyroid CancerRecurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences140 enrolled1 locationNCT06087068
Recruiting
Phase 3
A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer
Thyroid CancerRecurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1,199 enrolled1 locationNCT06082180